PTGS2
|
1.41
|
1.77
|
1.40
|
1.24
|
49.64
|
27.66
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
SERPINE1
|
2.71
|
2.36
|
2.48
|
3.90
|
7.18
|
11.42
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
DDIT3
|
−1.38
|
−1.25
|
1.14
|
1.11
|
7.34
|
10.51
|
DNA-damage-inducible transcript 3
|
FOSB
|
−1.12
|
1.03
|
1.57
|
1.59
|
8.98
|
9.31
|
FBJ murine osteosarcoma viral oncogene homolog B
|
BMP2
|
1.83
|
1.68
|
2.52
|
2.20
|
13.38
|
8.41
|
bone morphogenetic protein 2
|
PPP1R15A
|
−1.06
|
1.26
|
1.58
|
1.56
|
5.90
|
7.54
|
protein phosphatase 1, regulatory (inhibitor) subunit 15A
|
SGK1
|
3.05
|
2.82
|
3.25
|
2.47
|
9.88
|
7.18
|
serum/glucocorticoid regulated kinase 1
|
IL11
|
1.29
|
1.68
|
1.65
|
2.52
|
5.43
|
6.94
|
interleukin 11
|
DUSP1
|
1.03
|
1.09
|
1.07
|
1.29
|
4.69
|
6.73
|
dual specificity phosphatase 1
|
RCAN1
|
1.23
|
1.43
|
−1.02
|
1.10
|
6.34
|
6.71
|
regulator of calcineurin 1
|
E2F7
|
1.92
|
1.38
|
2.62
|
2.23
|
6.93
|
6.49
|
E2F transcription factor 7
|
VEGFA
|
1.89
|
2.60
|
1.96
|
2.75
|
5.28
|
6.44
|
vascular endothelial growth factor A
|
ITPRIP
|
1.80
|
1.65
|
1.38
|
1.51
|
6.38
|
6.23
|
inositol 1, 4, 5-triphosphate receptor interacting protein
|
ATF3
|
−1.46
|
−1.97
|
−1.30
|
−1.93
|
8.09
|
6.23
|
activating transcription factor 3
|
TRIB3
|
1.09
|
1.08
|
1.09
|
−1.09
|
4.61
|
6.11
|
tribbles homolog 3 (Drosophila)
|
PLEKHF1
|
1.04
|
1.39
|
1.28
|
1.37
|
3.67
|
6.01
|
pleckstrin homology domain containing, family F (with FYVE domain) member 1
|
PLAT
|
2.88
|
1.97
|
2.38
|
1.23
|
10.41
|
5.50
|
plasminogen activator, tissue
|
RCAN1
|
1.06
|
1.12
|
−1.13
|
−1.03
|
5.69
|
5.34
|
regulator of calcineurin 1
|
ASNS
|
−1.10
|
−1.15
|
−1.16
|
−1.32
|
4.54
|
5.30
|
asparagine synthetase
|
INHBE
|
1.05
|
1.07
|
−1.03
|
1.05
|
3.06
|
5.09
|
inhibin, beta E
|
JUN
|
1.47
|
1.38
|
2.00
|
2.01
|
4.23
|
5.08
|
jun oncogene
|
CTH
|
−1.33
|
−1.02
|
−1.29
|
1.21
|
3.22
|
4.91
|
cystathionase (cystathionine gamma-lyase)
|
HERPUD1
|
−1.01
|
1.16
|
−1.25
|
−1.12
|
3.48
|
4.79
|
homocysteine-inducible, endoplasmic reticulum stress-inducible
|
MTHFD2
|
1.68
|
1.43
|
1.52
|
1.65
|
4.22
|
4.75
|
methylenetetrahydrofolate dehydrogenase (NADP+dependent) 2
|
IL6
|
2.02
|
2.29
|
1.40
|
1.71
|
6.66
|
4.63
|
interleukin 6 (interferon, beta 2)
|
NDRG1
|
−1.04
|
−1.05
|
1.21
|
1.03
|
4.07
|
4.30
|
N-myc downstream regulated 1
|
CREB5
|
1.40
|
1.35
|
1.65
|
1.45
|
4.56
|
4.25
|
cAMP responsive element binding protein 5
|
ETS2
|
−1.18
|
1.43
|
1.05
|
1.20
|
2.82
|
4.02
|
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
|
ZNF295
|
1.03
|
1.28
|
1.25
|
1.41
|
2.70
|
3.77
|
zinc finger protein 295
|
IL1A
|
1.17
|
1.53
|
1.14
|
−1.03
|
3.40
|
3.75
|
interleukin 1, alpha
|
GPT2
|
−1.18
|
1.24
|
1.08
|
1.24
|
2.29
|
3.71
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
SLC3A2
|
1.53
|
1.22
|
1.06
|
−1.34
|
4.21
|
3.69
|
solute carrier family 3 (activators of dibasic and neutral amino acid transport) member 2
|
IRAK2
|
1.74
|
1.58
|
1.55
|
1.38
|
5.59
|
3.62
|
interleukin-1 receptor-associated kinase 2
|
CEBPG
|
1.19
|
1.12
|
1.24
|
1.12
|
3.65
|
3.46
|
CCAAT/enhancer binding protein (C/EBP), gamma
|
MTHFD2
|
1.46
|
1.28
|
1.32
|
1.46
|
4.18
|
3.42
|
methylenetetrahydrofolate dehydrogenase (NADP+dependent) 2
|
IER3
|
1.42
|
1.20
|
1.68
|
1.29
|
5.55
|
3.36
|
immediate early response 3
|
ETV5
|
1.56
|
1.53
|
1.41
|
1.60
|
3.15
|
3.34
|
ets variant 5
|
ITGA2
|
1.64
|
1.40
|
1.80
|
1.39
|
4.53
|
3.32
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
GEM
|
−1.11
|
−1.31
|
−1.02
|
−1.53
|
4.81
|
3.29
|
GTP binding protein overexpressed in skeletal muscle
|
DNAJB9
|
−1.19
|
1.04
|
−1.36
|
−1.27
|
3.73
|
3.22
|
DnaJ (Hsp40) homolog, subfamily B, member 9
|
NOV
|
1.06
|
1.37
|
−1.04
|
1.11
|
2.39
|
3.17
|
nephroblastoma overexpressed gene
|
FICD
|
1.39
|
1.34
|
1.21
|
1.26
|
2.63
|
3.16
|
FIC domain containing
|
NOG
|
1.24
|
−1.00
|
1.28
|
1.50
|
4.02
|
3.09
|
noggin
|
ST3GAL6
|
1.06
|
1.42
|
1.26
|
1.34
|
2.95
|
3.07
|
ST3 beta-galactoside alpha-2, 3-sialyltransferase 6
|
NFIL3
|
1.25
|
1.13
|
1.31
|
1.12
|
3.56
|
3.05
|
nuclear factor, interleukin 3 regulated
|
IL1B
|
1.58
|
1.35
|
2.01
|
1.55
|
7.94
|
3.00
|
interleukin 1, beta
|
GEM
|
−1.01
|
−1.00
|
1.11
|
−1.03
|
1.89
|
2.88
|
GTP binding protein overexpressed in skeletal muscle
|
SLC7A1
|
1.05
|
1.05
|
1.09
|
1.27
|
2.37
|
2.87
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
SGIP1
|
−1.13
|
1.04
|
1.46
|
1.50
|
3.23
|
2.84
|
SH3-domain GRB2-like (endophilin) interacting protein 1
|
SRPK2
|
1.05
|
1.11
|
1.02
|
1.06
|
2.37
|
2.83
|
SFRS protein kinase 2
|
CEBPB
|
−1.30
|
−1.21
|
1.04
|
−1.06
|
3.21
|
2.79
|
CCAAT/enhancer binding protein (C/EBP), beta
|
DUSP10
|
−1.02
|
−1.14
|
1.32
|
1.13
|
2.76
|
2.76
|
dual specificity phosphatase 10
|
C9orf150
|
1.33
|
1.48
|
1.09
|
−1.15
|
3.85
|
2.74
|
chromosome 9 open reading frame 150
|
SLC3A2
|
1.23
|
−1.13
|
−1.19
|
−1.28
|
3.05
|
2.66
|
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
|
SLC6A15
|
1.12
|
1.20
|
1.21
|
1.22
|
2.99
|
2.56
|
solute carrier 6 (neutral amino acid transporter), member 15
|
NCOA7
|
−1.07
|
1.13
|
−1.07
|
1.01
|
2.70
|
2.53
|
nuclear receptor coactivator 7
|
TGIF1
|
−1.28
|
−1.04
|
−1.15
|
−1.01
|
2.08
|
2.51
|
TGFB-induced factor homeobox 1
|
RND3
|
−1.45
|
1.03
|
−1.34
|
−1.17
|
2.49
|
2.49
|
Rho family GTPase 3
|
CBS
|
1.11
|
1.04
|
1.02
|
1.03
|
2.11
|
2.43
|
cystathionine-beta-synthase
|
NFKBIZ
|
−1.15
|
−1.07
|
1.00
|
1.02
|
2.01
|
2.43
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
STX3
|
−1.43
|
−1.43
|
−1.12
|
−1.08
|
1.89
|
2.42
|
syntaxin 3
|
SMOX
|
1.35
|
1.14
|
1.24
|
1.07
|
2.78
|
2.34
|
spermine oxidase
|
SAMD4A
|
1.25
|
−1.18
|
1.09
|
1.05
|
2.03
|
2.22
|
sterile alpha motif domain containing 4A
|
CLCN7
|
−1.08
|
1.23
|
1.06
|
1.31
|
1.72
|
2.21
|
chloride channel 7
|
MXD1
|
1.20
|
1.14
|
1.09
|
−1.02
|
2.12
|
2.20
|
MAX dimerization protein 1
|
ADAMTS1
|
−1.32
|
−1.24
|
−1.39
|
1.14
|
2.51
|
2.16
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
ASNS
|
−1.06
|
−1.02
|
−1.22
|
−1.09
|
2.17
|
2.15
|
asparagine synthetase
|
SIAH2
|
1.16
|
1.12
|
1.04
|
1.20
|
1.84
|
2.13
|
seven in absentia homolog 2 (Drosophila)
|
SQSTM1
|
1.20
|
−1.13
|
1.12
|
1.03
|
2.00
|
2.13
|
sequestosome 1
|
CCNL1
|
−1.03
|
1.04
|
1.16
|
1.07
|
1.87
|
2.12
|
cyclin L1
|
SLC38A1
|
1.27
|
1.27
|
1.47
|
1.20
|
1.81
|
2.12
|
solute carrier family 38, member 1
|
HMOX1
|
1.06
|
−1.26
|
−1.27
|
−1.69
|
2.22
|
2.11
|
heme oxygenase (decycling) 1
|
SYVN1
|
1.20
|
1.17
|
1.20
|
1.26
|
2.55
|
2.08
|
synovial apoptosis inhibitor 1, synoviolin
|
CTH
|
−1.08
|
−1.07
|
−1.03
|
−1.03
|
1.72
|
2.07
|
cystathionase (cystathionine gamma-lyase)
|
SLC25A25
|
1.21
|
1.06
|
1.19
|
1.17
|
2.03
|
2.01
|
solute carrier family 25 (mitochrondrial carrier; phosphate carrier), member 25
|
FZD2
|
−1.01
|
−1.16
|
1.14
|
1.04
|
−1.62
|
−2.08
|
frizzled homolog 2 (Drosophila)
|
ADIPOR2
|
−1.05
|
−1.18
|
−1.02
|
−1.04
|
−1.93
|
−2.23
|
adiponectin receptor 2
|
ENC1
|
−1.02
|
−1.15
|
1.08
|
1.21
|
−2.00
|
−2.81
|
ectodermal-neural cortex (with BTB-like domain)
|
B3GALNT1
|
−1.40
|
−1.48
|
−1.70
|
−1.43
|
−3.00
|
−3.92
|
beta-1, 3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
|
PPP1R3C
|
−1.23
|
−1.42
|
−1.26
|
−1.15
|
−5.14
|
−4.31
|
protein phosphatase 1, regulatory (inhibitor) subunit 3C
|
MT1F
|
−10.78
|
−8.64
|
−1.37
|
−1.26
|
−3.87
|
−4.34
|
metallothionein 1F
|
FADS2
|
−1.58
|
−1.55
|
−2.18
|
−1.61
|
−4.42
|
−4.77
|
fatty acid desaturase 2
|
ACLY
|
−2.36
|
−2.47
|
−2.02
|
−1.95
|
−4.87
|
−5.73
|
ATP citrate lyase
|
FADS1
|
−2.02
|
−2.05
|
−2.29
|
−1.58
|
−5.53
|
−6.42
|
fatty acid desaturase 1
|
FASN
|
−1.36
|
−1.23
|
−2.71
|
−1.76
|
−6.32
|
−6.96
|
fatty acid synthase
|
SLC25A1
|
−1.53
|
−2.67
|
−2.42
|
−2.79
|
−5.35
|
−7.44
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
LPIN1
|
−1.96
|
−1.83
|
−2.77
|
−2.24
|
−6.16
|
−8.24
|
lipin 1
|
INSIG1
|
−1.76
|
−1.91
|
−4.47
|
−2.98
|
−9.60
|
−11.16
|
insulin induced gene 1
|
LDLR
|
1.19
|
1.20
|
−2.09
|
−1.23
|
−13.16
|
−11.20
|
low density lipoprotein receptor
|
LSS
|
−1.35
|
−1.90
|
−5.08
|
−3.10
|
−10.77
|
−12.52
|
lanosterol synthase (2, 3-oxidosqualene-lanosterol cyclase)
|
DHCR7
|
1.01
|
−1.25
|
−4.74
|
−2.93
|
−14.01
|
−15.03
|
7-dehydrocholesterol reductase
|
SCD
|
−1.45
|
−1.40
|
−2.35
|
−1.79
|
−16.93
|
−16.08
|
stearoyl CoA desaturase (delta-9-desaturase)
|